Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04729322
What this trial is testing

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Who this might be right for
Metastatic Colorectal AdenocarcinomaMetastatic Small Intestinal AdenocarcinomaStage IV Colorectal Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00004195
What this trial is testing

Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Alabama at Birmingham 28
Testing effectiveness (Phase 2)Ended earlyNCT05435053
What this trial is testing

Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Ismail Gögenur 9
Early research (Phase 1)Active Not RecruitingNCT04460937
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Who this might be right for
Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+56 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT02870153
What this trial is testing

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
The First People's Hospital of Changzhou 60
Not applicableStudy completedNCT02425930
What this trial is testing

The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric CancerComplement Component DeficiencySurgery
First Affiliated Hospital, Sun Yat-Sen University 85
Testing effectiveness (Phase 2)UnknownNCT05042128
What this trial is testing

The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Cancer
Australasian Gastro-Intestinal Trials Group 158
Early research (Phase 1)Study completedNCT03132792
What this trial is testing

AFPᶜ³³²T in Advanced HCC

Who this might be right for
Hepatocellular CancerAFP Expressing Tumors
Adaptimmune 39
Not applicableNot Yet RecruitingNCT07685236
What this trial is testing

A Biomarker Exploration Study for Predicting Localization of Recurrence and Metastasis in Colorectal Cancer (PROBE Study)

Who this might be right for
Metastatic Colorectal Cancer (CRC)
The First Affiliated Hospital with Nanjing Medical University 586
Large-scale testing (Phase 3)Looking for participantsNCT07228832
What this trial is testing

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Summit Therapeutics 600
Not applicableStudy completedNCT06903039
What this trial is testing

NeoRes Study - Preoperative Chemotherapy in Colorectal Peritoneal Disease Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Who this might be right for
Colorectal Cancer MetastaticPeritoneal Metastases From Colorectal Cancer
Uppsala University 185
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Not applicableStudy completedNCT02140463
What this trial is testing

Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)

Who this might be right for
Metastatic Gastrointestinal CancerGenitourinary Cancer
Samsung Medical Center 229
Large-scale testing (Phase 3)Study completedNCT04737187
What this trial is testing

Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients

Who this might be right for
Refractory Metastatic Colorectal Cancer
Taiho Oncology, Inc. 492
Testing effectiveness (Phase 2)Study completedNCT01358812
What this trial is testing

FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colo-rectal Cancer
Gruppo Oncologico del Nord-Ovest 37
Testing effectiveness (Phase 2)Ended earlyNCT00183807
What this trial is testing

Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Southern California 6
Testing effectiveness (Phase 2)Study completedNCT01181609
What this trial is testing

Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 54
Testing effectiveness (Phase 2)UnknownNCT05095636
What this trial is testing

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Gastric CancerMetastasis
Fudan University 102
Testing effectiveness (Phase 2)Ended earlyNCT05397171
What this trial is testing

A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours

Who this might be right for
Urinary Bladder NeoplasmsColorectal CancerCarcinoma, Non-Small-Cell Lung
AstraZeneca 17
Testing effectiveness (Phase 2)Looking for participantsNCT05733598
What this trial is testing

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Cancer
Replimune, Inc. 60
Next Page
4